SPECIFIC AND SENSITIVE DETERMINATION OF DIGOXIN AND METABOLITES IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH CYCLODEXTRIN SOLID-PHASE EXTRACTION AND PRECOLUMN FLUORESCENCE DERIVATIZATION
Mc. Tzou et al., SPECIFIC AND SENSITIVE DETERMINATION OF DIGOXIN AND METABOLITES IN HUMAN SERUM BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH CYCLODEXTRIN SOLID-PHASE EXTRACTION AND PRECOLUMN FLUORESCENCE DERIVATIZATION, Journal of pharmaceutical and biomedical analysis, 13(12), 1995, pp. 1531-1540
A precolumn fluorescence derivatization high performance liquid chroma
tographic method has been developed for the simultaneous determination
of digoxin and its metabolites digoxigenin bisdigitoxoside, digoxigen
in monodigitoxoside digoxigenin, and dihydrodigoxin (20-R and 20-S epi
mers) in human serum. Digoxin and its metabolites were extracted from
serum samples (containing digitoxin as internal standard) with a cyclo
dextrin solid-phase extraction (SPE) column. Fluorescent derivatives w
ere formed by reaction of the analytes with 1-naphthoyl chloride in th
e presence of 4-dimethylaminopyridine under a nitrogen atmosphere in a
glove box with controlled relative humidity (26% r.h. or less). The d
erivatives were isolated using cyclodextrin and Cl SPE columns sequent
ially, and determined by HPLC using silica column separation and fluor
escence detection. Calibration curves were linear over the concentrati
on range from 0.25 to 4.0 ng ml(-1). Recoveries of digoxin and its met
abolites from serum ranged from 62 to 86%, and coefficients of variati
on from repetitive analyses ranged from 6.9 to 20.9% and from 5.8 to 1
2.2% at 0.5 ng ml(-1) and 2.0 ng ml(-1), respectively. This method has
been shown capable of specifically determining digoxin and its major
metabolites in serum, and has been successfully used in the determinat
ion of digoxin and its metabolites in serum samples collected from pat
ients undergoing digoxin therapy. This method thus permits the investi
gation of digoxin metabolism and pharmacokinetics after the administra
tion of commercial dosage forms.